February 20, 2013Clinical/Scientific Notes
Niemann-pick type c is frequent in adult ataxia with cognitive decline and vertical gaze palsy
Julia Schicks, Jennifer Müller vom Hagen, Peter Bauer, Stefanie Beck-Wödl, Saskia Biskup, Ingeborg Krägeloh-Mann, Ludger Schöls, Matthis Synofzik
First published February 20, 2013, DOI: https://doi.org/10.1212/WNL.0b013e31828869f9
Julia Schicks
From the Department of Neurodegenerative Diseases, Hertie-Institute for Clinical Brain Research (J.S., J.M.v.H., S.B., L.S., M.S.), German Research Center for Neurodegenerative Diseases (DZNE) (J.S., J.M.v.H., S.B., L.S., M.S.), Department of Medical Genetics (P.B., S.B.-W.), and Department of Neuropediatrics (I.K.-M.), University of Tübingen, Tübingen; and CeGaT GmbH (S.B.), Tübingen, Germany.
Jennifer Müller vom Hagen
From the Department of Neurodegenerative Diseases, Hertie-Institute for Clinical Brain Research (J.S., J.M.v.H., S.B., L.S., M.S.), German Research Center for Neurodegenerative Diseases (DZNE) (J.S., J.M.v.H., S.B., L.S., M.S.), Department of Medical Genetics (P.B., S.B.-W.), and Department of Neuropediatrics (I.K.-M.), University of Tübingen, Tübingen; and CeGaT GmbH (S.B.), Tübingen, Germany.
Peter Bauer
From the Department of Neurodegenerative Diseases, Hertie-Institute for Clinical Brain Research (J.S., J.M.v.H., S.B., L.S., M.S.), German Research Center for Neurodegenerative Diseases (DZNE) (J.S., J.M.v.H., S.B., L.S., M.S.), Department of Medical Genetics (P.B., S.B.-W.), and Department of Neuropediatrics (I.K.-M.), University of Tübingen, Tübingen; and CeGaT GmbH (S.B.), Tübingen, Germany.
Stefanie Beck-Wödl
From the Department of Neurodegenerative Diseases, Hertie-Institute for Clinical Brain Research (J.S., J.M.v.H., S.B., L.S., M.S.), German Research Center for Neurodegenerative Diseases (DZNE) (J.S., J.M.v.H., S.B., L.S., M.S.), Department of Medical Genetics (P.B., S.B.-W.), and Department of Neuropediatrics (I.K.-M.), University of Tübingen, Tübingen; and CeGaT GmbH (S.B.), Tübingen, Germany.
Saskia Biskup
From the Department of Neurodegenerative Diseases, Hertie-Institute for Clinical Brain Research (J.S., J.M.v.H., S.B., L.S., M.S.), German Research Center for Neurodegenerative Diseases (DZNE) (J.S., J.M.v.H., S.B., L.S., M.S.), Department of Medical Genetics (P.B., S.B.-W.), and Department of Neuropediatrics (I.K.-M.), University of Tübingen, Tübingen; and CeGaT GmbH (S.B.), Tübingen, Germany.
Ingeborg Krägeloh-Mann
From the Department of Neurodegenerative Diseases, Hertie-Institute for Clinical Brain Research (J.S., J.M.v.H., S.B., L.S., M.S.), German Research Center for Neurodegenerative Diseases (DZNE) (J.S., J.M.v.H., S.B., L.S., M.S.), Department of Medical Genetics (P.B., S.B.-W.), and Department of Neuropediatrics (I.K.-M.), University of Tübingen, Tübingen; and CeGaT GmbH (S.B.), Tübingen, Germany.
Ludger Schöls
From the Department of Neurodegenerative Diseases, Hertie-Institute for Clinical Brain Research (J.S., J.M.v.H., S.B., L.S., M.S.), German Research Center for Neurodegenerative Diseases (DZNE) (J.S., J.M.v.H., S.B., L.S., M.S.), Department of Medical Genetics (P.B., S.B.-W.), and Department of Neuropediatrics (I.K.-M.), University of Tübingen, Tübingen; and CeGaT GmbH (S.B.), Tübingen, Germany.
Matthis Synofzik
From the Department of Neurodegenerative Diseases, Hertie-Institute for Clinical Brain Research (J.S., J.M.v.H., S.B., L.S., M.S.), German Research Center for Neurodegenerative Diseases (DZNE) (J.S., J.M.v.H., S.B., L.S., M.S.), Department of Medical Genetics (P.B., S.B.-W.), and Department of Neuropediatrics (I.K.-M.), University of Tübingen, Tübingen; and CeGaT GmbH (S.B.), Tübingen, Germany.